Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits
Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct symptoms, many cases have...
Search results for "Phase 3 trial"
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s obesity drug candidate "EPPE" has...
GC Pharma Partners with France’s Osivax to Develop Next-Generation Combination Flu Vaccine
GC Pharma has entered into a strategic partnership with French biotech firm Osivax to develop and commercialize a...
Stem Cell Pioneer Kim Dong-wook Wins KY Cha Academic Award for Breakthrough Parkinson’s Therapy
Professor Kim Dong-wook of Yonsei University College of Medicine, a pioneer in human embryonic stem cell-based...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Regenerative Technique Aims to Solve Rotator Cuff Re-Tears by Rebuilding the Tendon-Bone Junction
When surgeons reattach a torn shoulder tendon to the bone, a frustrating setback often occurs over time: the repair...
Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study
An animal study has revealed that combining GC Green Cross Wellbeing’s human placental hydrolysate treatment, Laennec...
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...
Zinc and Selenium Deficiencies Linked to Heightened Inflammation in Critically Ill Patients
For families with loved ones in an intensive care unit , lab reports often feature unfamiliar line items alongside...
550 Days in Limbo: Groups Demand 100-Day Fast-Track Insurance Coverage for Breakthrough PAH Drug Winrevair
With national health insurance coverage for the new pulmonary arterial hypertension treatment Winrevair (active...